HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PMS 601

structure in first source

Also Known As:

PMS-601; PMS601

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - PMS 601: 4

Experts

1.	Clayette, P: 3 articles (11/2000 - 06/2000)
2.	Dereuddre-Bosquet, N: 3 articles (11/2000 - 06/2000)
3.	Dormont, D: 3 articles (11/2000 - 06/2000)
4.	Godfroid, J J: 3 articles (11/2000 - 06/2000)
5.	Heymans, F: 3 articles (11/2000 - 06/2000)
6.	Lamouri, A: 3 articles (11/2000 - 06/2000)
7.	Martin, M: 3 articles (11/2000 - 06/2000)
8.	Serradji, N: 3 articles (11/2000 - 06/2000)
9.	Fichet, G: 2 articles (11/2000 - 06/2000)
10.	Clayette, Pascal: 1 article (08/2009)

Related Diseases

1.	HIV Infections (HIV Infection) 11/01/2000 - "These results suggest that PMS-601 is of potential value as an adjuvant treatment for HIV infection." 06/01/2000 - "Altogether, these results suggest that PAF-receptor antagonists, and particularly PMS-601, could be of potential value as treatment adjuvants in HIV infection."
2.	Neurocognitive Disorders (Clerambault Syndrome) 08/18/2009 - "These observations support the further development of PMS-601 as an adjunctive therapy for HIV-1 associated neurocognitive disorders."
3.	Encephalitis (Encephalitis, Rasmussen) 08/18/2009 - "The neuroregulatory activities of PMS-601, a platelet activating factor antagonist, were investigated in laboratory and animal models of HIV-1 encephalitis (HIVE). "
4.	Dementia (Dementias) 06/01/2000 - "Although its mode of action is not clearly defined, these data suggest that PMS 601, which displays no effect on acellular reverse transcriptase or protease tests, deserves further investigation in the treatment of HIV-1-associated dementia."

Related Drugs and Biologics

1.	RNA-Directed DNA Polymerase (Reverse Transcriptase)
2.	Platelet Activating Factor
3.	Peptide Hydrolases (Proteases)

Related Therapies and Procedures

1.	Therapeutics